Mollie Barnes

6 days ago | theeastsiderla.com | Mollie Barnes

Eagle Rock – In 1920, the silent drama Cup of Fury was the first film shot at Occidental College Since then, its tree-lined quad and columned buildings have appeared in scores of films, TV shows, and commercials. Movie stars have walked the same paths as students heading to economics  class. The roster runs the gamut of film history. The Marx Brothers appeared on the cover of Time Magazine in 1932 while shooting Horse Feathers on Patterson Field.

Aug 27, 2024 | biospace.com | Mollie Barnes

In recent years as Big Pharma has shied away from M&A to restock their pipelines, they have instead turned to licensing deals to add new assets. But occasionally, some deals just don’t work out, and these assets are returned to the biotechs they came from.

Aug 7, 2024 | biospace.com | Mollie Barnes

After a rough patch for biotech investment in early 2023, the immunology and inflammation (I&I) space rejuvenated the industry with Merck’s blockbuster acquisition of Prometheus Biosciences for $10.8 billion. Overall, the therapeutic I&I space saw $12.3 billion in M&A action last year, according to data from biotech entrepreneur Andrew Pannu. “I&I has always been an area of high particular interest for pharmaceutical companies . . . driven primarily by the idea that . . .

Jul 29, 2024 | biospace.com | Mollie Barnes

Hand passing off bag of money over financial background/Taylor Tieden for BioSpace This year has seen a boom in biopharma mergers and acquisitions, with six acquisitions over a billion dollars so far. In light of the massive revenues pharma companies are generating in the obesity space and the pressure many companies are under from looming loss of exclusivity (LOE) on top drugs, analysts don’t see it slowing down anytime soon.

Jul 29, 2024 | biospace.com | Mollie Barnes

Pictured: Illustration of a computer choosing from a display of candidate profiles/iStock, Piscine AI is everywhere, whether we realize it or not. That’s the sentiment held by Liz Nguyen, an advisor to emerging biotech companies who previously worked as the senior vice president of talent and culture at the biotech Surrozen. Artificial intelligence, or AI, is already operating behind the scenes in many aspects of business, including recruitment and retention of employees within biotech.